PharmaShots | Incisive News in 3 Shots

Subscribe Now

SetPoint Medical

SetPoint Medical Reports PMA Submission of SetPoint System to the US FDA for Treating Rheumatoid Arthritis

SetPoint Medical Reports PMA Submission of SetPoint System to the US FDA for Treating Rheumatoid Arthritis

December 10, 2024

SetPoint Medical Reports the US FDA’s IDE Approval to Initiate Neuroimmune Modulation Platform’s Evaluation for Relapsing-Remitting Multiple Sclerosis

SetPoint Medical Reports the US FDA’s IDE Approval to Initiate Neuroimmune Modulation Platform’s Evaluation for Relapsing-Remittin...

October 3, 2024

SetPoint Medical’s Neuroimmune Modulation Platform Obtains the US FDA’s Breakthrough Device Designation to Treat Multiple Sclerosis

SetPoint Medical’s Neuroimmune Modulation Platform Obtains the US FDA’s Breakthrough Device Designation to Treat Multiple Sclerosi...

March 14, 2024

Contact Us

First Floor, B-66, Sector 63 Noida, Uttar Pradesh, INDIA - 201301
+91-120 428 0707
connect@pharmashots.com
Newsletter

Our Information

Follow Us